Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 33 entries
Sorted by: Best Match Show Resources per page
Seizures Due to a KCNQ2 Mutation: Treatment with Vitamin B6.

JIMD reports

Reid ES, Williams H, Stabej Ple Q, James C, Ocaka L, Bacchelli C, Footitt EJ, Boyd S, Cleary MA, Mills PB, Clayton PT.
PMID: 26446091
JIMD Rep. 2016;27:79-84. doi: 10.1007/8904_2015_460. Epub 2015 Oct 08.

There is increasing evidence that vitamin B6, given either as pyridoxine or pyridoxal 5'-phosphate, can sometimes result in improved seizure control in idiopathic epilepsy. Whole-exome sequencing was used to identify a de novo mutation (c.629G>A; p.Arg210His) in KCNQ2 in...

Cite
Reid ES, Williams H, Stabej Ple Q, et al. Seizures Due to a KCNQ2 Mutation: Treatment with Vitamin B6. JIMD Rep. 2015;27:79-84doi: 10.1007/8904_2015_460.
Reid, E. S., Williams, H., Stabej, P. l. e. . Q., James, C., Ocaka, L., Bacchelli, C., Footitt, E. J., Boyd, S., Cleary, M. A., Mills, P. B., & Clayton, P. T. (2016). Seizures Due to a KCNQ2 Mutation: Treatment with Vitamin B6. JIMD reports, 2779-84. https://doi.org/10.1007/8904_2015_460
Reid, Emma S, et al. "Seizures Due to a KCNQ2 Mutation: Treatment with Vitamin B6." JIMD reports vol. 27 (2016): 79-84. doi: https://doi.org/10.1007/8904_2015_460
Reid ES, Williams H, Stabej Ple Q, James C, Ocaka L, Bacchelli C, Footitt EJ, Boyd S, Cleary MA, Mills PB, Clayton PT. Seizures Due to a KCNQ2 Mutation: Treatment with Vitamin B6. JIMD Rep. 2016;27:79-84. doi: 10.1007/8904_2015_460. Epub 2015 Oct 08. PMID: 26446091; PMCID: PMC5580730.
Copy Download .nbib Format: NLM
The formation of bicyclo[n.2.0]alkan-1-ols from the reaction of the lithium enolates of simple ketones and phenyl vinyl sulfoxide.

Organic & biomolecular chemistry

Loughlin WA, McCleary MA.
PMID: 12929665
Org Biomol Chem. 2003 Apr 21;1(8):1347-53. doi: 10.1039/b208365e.

The enolates generated from cyclopentanone, cycloheptanone or cyclooctanone and LDA at -78 degrees C in THF react with (+/-)-phenyl vinyl sulfoxide under controlled conditions of temperature, reaction time, and concentration. Upon oxidation with MCPBA of the product mixtures, the...

Cite
Loughlin WA, McCleary MA. The formation of bicyclo[n.2.0]alkan-1-ols from the reaction of the lithium enolates of simple ketones and phenyl vinyl sulfoxide. Org Biomol Chem. 2003;1(8):1347-53doi: 10.1039/b208365e.
Loughlin, W. A., & McCleary, M. A. (2003). The formation of bicyclo[n.2.0]alkan-1-ols from the reaction of the lithium enolates of simple ketones and phenyl vinyl sulfoxide. Organic & biomolecular chemistry, 1(8), 1347-53. https://doi.org/10.1039/b208365e
Loughlin, Wendy A, and McCleary, Michelle A. "The formation of bicyclo[n.2.0]alkan-1-ols from the reaction of the lithium enolates of simple ketones and phenyl vinyl sulfoxide." Organic & biomolecular chemistry vol. 1,8 (2003): 1347-53. doi: https://doi.org/10.1039/b208365e
Loughlin WA, McCleary MA. The formation of bicyclo[n.2.0]alkan-1-ols from the reaction of the lithium enolates of simple ketones and phenyl vinyl sulfoxide. Org Biomol Chem. 2003 Apr 21;1(8):1347-53. doi: 10.1039/b208365e. PMID: 12929665.
Copy Download .nbib Format: NLM
Preseason heat-acclimatization guidelines for secondary school athletics.

Journal of athletic training

Casa DJ, Csillan D, Armstrong LE, Baker LB, Bergeron MF, Buchanan VM, Carroll MJ, Cleary MA, Eichner ER, Ferrara MS, Fitzpatrick TD, Hoffman JR, Kenefick RW, Klossner DA, Knight JC, Lennon SA, Lopez RM, Matava MJ, O'Connor FG, Peterson BC, Rice SG, Robinson BK, Shriner RJ, West MS, Yeargin SW.
PMID: 19478834
J Athl Train. 2009 May-Jun;44(3):332-3. doi: 10.4085/1062-6050-44.3.332.

No abstract available.

Cite
Casa DJ, Csillan D, et al. Preseason heat-acclimatization guidelines for secondary school athletics. J Athl Train. 2009;44(3):332-3doi: 10.4085/1062-6050-44.3.332.
Casa, D. J., Csillan, D., Armstrong, L. E., Baker, L. B., Bergeron, M. F., Buchanan, V. M., Carroll, M. J., Cleary, M. A., Eichner, E. R., Ferrara, M. S., Fitzpatrick, T. D., Hoffman, J. R., Kenefick, R. W., Klossner, D. A., Knight, J. C., Lennon, S. A., Lopez, R. M., Matava, M. J., O'Connor, F. G., Peterson, B. C., Rice, S. G., Robinson, B. K., Shriner, R. J., West, M. S., & Yeargin, S. W. (2009). Preseason heat-acclimatization guidelines for secondary school athletics. Journal of athletic training, 44(3), 332-3. https://doi.org/10.4085/1062-6050-44.3.332
Casa, Douglas J, et al. "Preseason heat-acclimatization guidelines for secondary school athletics." Journal of athletic training vol. 44,3 (2009): 332-3. doi: https://doi.org/10.4085/1062-6050-44.3.332
Casa DJ, Csillan D, Armstrong LE, Baker LB, Bergeron MF, Buchanan VM, Carroll MJ, Cleary MA, Eichner ER, Ferrara MS, Fitzpatrick TD, Hoffman JR, Kenefick RW, Klossner DA, Knight JC, Lennon SA, Lopez RM, Matava MJ, O'Connor FG, Peterson BC, Rice SG, Robinson BK, Shriner RJ, West MS, Yeargin SW. Preseason heat-acclimatization guidelines for secondary school athletics. J Athl Train. 2009 May-Jun;44(3):332-3. doi: 10.4085/1062-6050-44.3.332. PMID: 19478834; PMCID: PMC2681206.
Copy Download .nbib Format: NLM
FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells.

F1000Research

Conrad W, Major MB, Cleary MA, Ferrer M, Roberts B, Marine S, Chung N, Arthur WT, Chien AJ, Berndt JD, Moon RT.
PMID: 24358901
F1000Res. 2013 May 31;2:134. doi: 10.12688/f1000research.2-134.v1. eCollection 2013.

The inability of targeted BRAF inhibitors to produce long-lasting improvement in the clinical outcome of melanoma highlights a need to identify additional approaches to inhibit melanoma growth. Recent studies have shown that activation of the Wnt/β-catenin pathway decreases tumor...

Cite
Conrad W, Major MB, Cleary MA, et al. FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells. F1000Res. 2013;2:134doi: 10.12688/f1000research.2-134.v1.
Conrad, W., Major, M. B., Cleary, M. A., Ferrer, M., Roberts, B., Marine, S., Chung, N., Arthur, W. T., Chien, A. J., Berndt, J. D., & Moon, R. T. (2013). FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells. F1000Research, 2134. https://doi.org/10.12688/f1000research.2-134.v1
Conrad, Willliam, et al. "FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells." F1000Research vol. 2 (2013): 134. doi: https://doi.org/10.12688/f1000research.2-134.v1
Conrad W, Major MB, Cleary MA, Ferrer M, Roberts B, Marine S, Chung N, Arthur WT, Chien AJ, Berndt JD, Moon RT. FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells. F1000Res. 2013 May 31;2:134. doi: 10.12688/f1000research.2-134.v1. eCollection 2013. PMID: 24358901; PMCID: PMC3829391.1.
Copy Download .nbib Format: NLM
Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T.

IEEE transactions on radiation and plasma medical sciences

Kaggie JD, Deen S, Kessler DA, McLean MA, Buonincontri G, Schulte RF, Addley H, Sala E, Brenton J, Graves MJ, Gallagher FA.
PMID: 32066996
IEEE Trans Radiat Plasma Med Sci. 2019 Jul;3(4):509-515. doi: 10.1109/TRPMS.2019.2905366. Epub 2019 Mar 15.

Multiparametric magnetic resonance imaging (MRI) can be used to characterize many cancer subtypes including ovarian cancer. Quantitative mapping of MRI relaxation values, such as

Cite
Kaggie JD, Deen S, Kessler DA, et al. Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T. IEEE Trans Radiat Plasma Med Sci. 2019;3(4):509-515doi: 10.1109/TRPMS.2019.2905366.
Kaggie, J. D., Deen, S., Kessler, D. A., McLean, M. A., Buonincontri, G., Schulte, R. F., Addley, H., Sala, E., Brenton, J., Graves, M. J., & Gallagher, F. A. (2019). Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T. IEEE transactions on radiation and plasma medical sciences, 3(4), 509-515. https://doi.org/10.1109/TRPMS.2019.2905366
Kaggie, Joshua D, et al. "Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T." IEEE transactions on radiation and plasma medical sciences vol. 3,4 (2019): 509-515. doi: https://doi.org/10.1109/TRPMS.2019.2905366
Kaggie JD, Deen S, Kessler DA, McLean MA, Buonincontri G, Schulte RF, Addley H, Sala E, Brenton J, Graves MJ, Gallagher FA. Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T. IEEE Trans Radiat Plasma Med Sci. 2019 Jul;3(4):509-515. doi: 10.1109/TRPMS.2019.2905366. Epub 2019 Mar 15. PMID: 32066996; PMCID: PMC7025887.
Copy Download .nbib Format: NLM
Useful Waste: The Utility of Urine in History.

Urology

McLeay M, Austenfeld M, Nangia AK.
PMID: 34186131
Urology. 2021 Oct;156:2-5. doi: 10.1016/j.urology.2021.06.018. Epub 2021 Jun 27.

No abstract available.

Cite
McLeay M, Austenfeld M, Nangia AK. Useful Waste: The Utility of Urine in History. Urology. 2021;156:2-5doi: 10.1016/j.urology.2021.06.018.
McLeay, M., Austenfeld, M., & Nangia, A. K. (2021). Useful Waste: The Utility of Urine in History. Urology, 1562-5. https://doi.org/10.1016/j.urology.2021.06.018
McLeay, Matthew, et al. "Useful Waste: The Utility of Urine in History." Urology vol. 156 (2021): 2-5. doi: https://doi.org/10.1016/j.urology.2021.06.018
McLeay M, Austenfeld M, Nangia AK. Useful Waste: The Utility of Urine in History. Urology. 2021 Oct;156:2-5. doi: 10.1016/j.urology.2021.06.018. Epub 2021 Jun 27. PMID: 34186131.
Copy Download .nbib Format: NLM
Assessing screening, brief intervention, and referral to treatment (SBIRT) compliance and disparities for pediatric inpatients at a tertiary care facility.

Journal of pediatric surgery

Roubil JG, Hazeltine MD, Bludevich BM, Aidlen JT, Pustis N, Ferrante C, Hirsh MP, Cleary MA.
PMID: 34740443
J Pediatr Surg. 2021 Oct 05; doi: 10.1016/j.jpedsurg.2021.09.048. Epub 2021 Oct 05.

BACKGROUND: Pediatric trauma centers are required to screen patients for alcohol or other drug use (AOD), Briefly Intervene, and Refer these patients to Treatment (SBIRT) to meet Level 1 and 2 trauma center requirements set by the American College...

Cite
Roubil JG, Hazeltine MD, Bludevich BM, et al. Assessing screening, brief intervention, and referral to treatment (SBIRT) compliance and disparities for pediatric inpatients at a tertiary care facility. J Pediatr Surg. 2021;doi: 10.1016/j.jpedsurg.2021.09.048.
Roubil, J. G., Hazeltine, M. D., Bludevich, B. M., Aidlen, J. T., Pustis, N., Ferrante, C., Hirsh, M. P., & Cleary, M. A. (2021). Assessing screening, brief intervention, and referral to treatment (SBIRT) compliance and disparities for pediatric inpatients at a tertiary care facility. Journal of pediatric surgery, . https://doi.org/10.1016/j.jpedsurg.2021.09.048
Roubil, John G, et al. "Assessing screening, brief intervention, and referral to treatment (SBIRT) compliance and disparities for pediatric inpatients at a tertiary care facility." Journal of pediatric surgery vol. (2021). doi: https://doi.org/10.1016/j.jpedsurg.2021.09.048
Roubil JG, Hazeltine MD, Bludevich BM, Aidlen JT, Pustis N, Ferrante C, Hirsh MP, Cleary MA. Assessing screening, brief intervention, and referral to treatment (SBIRT) compliance and disparities for pediatric inpatients at a tertiary care facility. J Pediatr Surg. 2021 Oct 05; doi: 10.1016/j.jpedsurg.2021.09.048. Epub 2021 Oct 05. PMID: 34740443.
Copy Download .nbib Format: NLM
Multi-site benchmarking of clinical .

Journal of magnetic resonance (San Diego, Calif. : 1997)

Sánchez-Heredia JD, Olin RB, McLean MA, Laustsen C, Hansen AE, Hanson LG, Ardenkjær-Larsen JH.
PMID: 32755748
J Magn Reson. 2020 Sep;318:106798. doi: 10.1016/j.jmr.2020.106798. Epub 2020 Jul 27.

A quality assurance protocol for RF coils is proposed, which can be used for volume (Tx/Rx) and surface (Rx) coils. Following this protocol, a benchmarking of seven coils (from three different MR sites) dedicated to

Cite
Sánchez-Heredia JD, Olin RB, McLean MA, et al. Multi-site benchmarking of clinical . J Magn Reson. 2020;318:106798doi: 10.1016/j.jmr.2020.106798.
Sánchez-Heredia, J. D., Olin, R. B., McLean, M. A., Laustsen, C., Hansen, A. E., Hanson, L. G., & Ardenkjær-Larsen, J. H. (2020). Multi-site benchmarking of clinical . Journal of magnetic resonance (San Diego, Calif. : 1997), 318106798. https://doi.org/10.1016/j.jmr.2020.106798
Sánchez-Heredia, Juan Diego, et al. "Multi-site benchmarking of clinical ." Journal of magnetic resonance (San Diego, Calif. : 1997) vol. 318 (2020): 106798. doi: https://doi.org/10.1016/j.jmr.2020.106798
Sánchez-Heredia JD, Olin RB, McLean MA, Laustsen C, Hansen AE, Hanson LG, Ardenkjær-Larsen JH. Multi-site benchmarking of clinical . J Magn Reson. 2020 Sep;318:106798. doi: 10.1016/j.jmr.2020.106798. Epub 2020 Jul 27. PMID: 32755748; PMCID: PMC7501735.
Copy Download .nbib Format: NLM
The Activin/FLRG pathway associates with poor COVID-19 outcomes in hospitalized patients.

Molecular and cellular biology

McAleavy M, Zhang Q, Ehmann PJ, Xu J, Wipperman MF, Ajithdoss D, Pan L, Wakai M, Simonson R, Gadi A, Oyejide A, Hamon SC, Boyapati A, Morton LG, Shavlakadze T, Kyratsous CA, Glass DJ.
PMID: 34723652
Mol Cell Biol. 2021 Nov 01;MCB0046721. doi: 10.1128/MCB.00467-21. Epub 2021 Nov 01.

A subset of hospitalized COVID-19 patients, particularly the aged and those with co-morbidities, develop the most severe form of the disease, characterized by Acute Respiratory Disease Syndrome (ARDS), coincident with experiencing a "cytokine storm." Here, we demonstrate that cytokines...

Cite
McAleavy M, Zhang Q, Ehmann PJ, et al. The Activin/FLRG pathway associates with poor COVID-19 outcomes in hospitalized patients. Mol Cell Biol. 2021;MCB0046721doi: 10.1128/MCB.00467-21.
McAleavy, M., Zhang, Q., Ehmann, P. J., Xu, J., Wipperman, M. F., Ajithdoss, D., Pan, L., Wakai, M., Simonson, R., Gadi, A., Oyejide, A., Hamon, S. C., Boyapati, A., Morton, L. G., Shavlakadze, T., Kyratsous, C. A., & Glass, D. J. (2021). The Activin/FLRG pathway associates with poor COVID-19 outcomes in hospitalized patients. Molecular and cellular biology, MCB0046721. https://doi.org/10.1128/MCB.00467-21
McAleavy, Megan, et al. "The Activin/FLRG pathway associates with poor COVID-19 outcomes in hospitalized patients." Molecular and cellular biology vol. (2021): MCB0046721. doi: https://doi.org/10.1128/MCB.00467-21
McAleavy M, Zhang Q, Ehmann PJ, Xu J, Wipperman MF, Ajithdoss D, Pan L, Wakai M, Simonson R, Gadi A, Oyejide A, Hamon SC, Boyapati A, Morton LG, Shavlakadze T, Kyratsous CA, Glass DJ. The Activin/FLRG pathway associates with poor COVID-19 outcomes in hospitalized patients. Mol Cell Biol. 2021 Nov 01;MCB0046721. doi: 10.1128/MCB.00467-21. Epub 2021 Nov 01. PMID: 34723652.
Copy Download .nbib Format: NLM
FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells.

F1000Research

Conrad W, Major MB, Cleary MA, Ferrer M, Roberts B, Marine S, Chung N, Arthur WT, Moon RT, Berndt JD, Chien AJ.
PMID: 24358901
F1000Res. 2013 May 31;2:134. doi: 10.12688/f1000research.2-134.v2. eCollection 2013.

The inability of targeted BRAF inhibitors to produce long-lasting improvement in the clinical outcome of melanoma highlights a need to identify additional approaches to inhibit melanoma growth. Recent studies have shown that activation of the Wnt/β-catenin pathway decreases tumor...

Cite
Conrad W, Major MB, Cleary MA, et al. FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells. F1000Res. 2013;2:134doi: 10.12688/f1000research.2-134.v2.
Conrad, W., Major, M. B., Cleary, M. A., Ferrer, M., Roberts, B., Marine, S., Chung, N., Arthur, W. T., Moon, R. T., Berndt, J. D., & Chien, A. J. (2013). FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells. F1000Research, 2134. https://doi.org/10.12688/f1000research.2-134.v2
Conrad, Willliam, et al. "FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells." F1000Research vol. 2 (2013): 134. doi: https://doi.org/10.12688/f1000research.2-134.v2
Conrad W, Major MB, Cleary MA, Ferrer M, Roberts B, Marine S, Chung N, Arthur WT, Moon RT, Berndt JD, Chien AJ. FAM129B is a novel regulator of Wnt/β-catenin signal transduction in melanoma cells. F1000Res. 2013 May 31;2:134. doi: 10.12688/f1000research.2-134.v2. eCollection 2013. PMID: 24358901; PMCID: PMC3829391.
Copy Download .nbib Format: NLM
Hospitals' legal responsibility for trainees.

Urban health

Hirsh HL, McLean MA.
PMID: 10269279
Urban Health. 1984 Sep;13(8):34-9.

No abstract available.

Cite
Hirsh HL, McLean MA. Hospitals' legal responsibility for trainees. Urban Health. 1984;13(8):34-9
Hirsh, H. L., & McLean, M. A. (1984). Hospitals' legal responsibility for trainees. Urban health, 13(8), 34-9.
Hirsh, H L, and McLean, M A. "Hospitals' legal responsibility for trainees." Urban health vol. 13,8 (1984): 34-9.
Hirsh HL, McLean MA. Hospitals' legal responsibility for trainees. Urban Health. 1984 Sep;13(8):34-9. PMID: 10269279.
Copy Download .nbib Format: NLM
Translating .

JCO precision oncology

Casey RT, McLean MA, Madhu B, Challis BG, Ten Hoopen R, Roberts T, Clark GR, Pittfield D, Simpson HL, Bulusu VR, Allinson K, Happerfield L, Park SM, Marker A, Giger O, Maher ER, Gallagher FA.
PMID: 30949620
JCO Precis Oncol. 2018 Mar 29;2:1-12. doi: 10.1200/PO.17.00191.

PURPOSE: Mutations in the mitochondrial enzyme succinate dehydrogenase (SDH) subunit genes are associated with a wide spectrum of tumours including phaeochromocytoma and paraganglioma (PPGL) 1, 2, gastrointestinal stromal tumours (GIST) 3, renal cell carcinoma (RCC) 4 and pituitary adenomas5....

Cite
Casey RT, McLean MA, Madhu B, et al. Translating . JCO Precis Oncol. 2018;2:1-12doi: 10.1200/PO.17.00191.
Casey, R. T., McLean, M. A., Madhu, B., Challis, B. G., Ten Hoopen, R., Roberts, T., Clark, G. R., Pittfield, D., Simpson, H. L., Bulusu, V. R., Allinson, K., Happerfield, L., Park, S. M., Marker, A., Giger, O., Maher, E. R., & Gallagher, F. A. (2018). Translating . JCO precision oncology, 21-12. https://doi.org/10.1200/PO.17.00191
Casey, Ruth T, et al. "Translating ." JCO precision oncology vol. 2 (2018): 1-12. doi: https://doi.org/10.1200/PO.17.00191
Casey RT, McLean MA, Madhu B, Challis BG, Ten Hoopen R, Roberts T, Clark GR, Pittfield D, Simpson HL, Bulusu VR, Allinson K, Happerfield L, Park SM, Marker A, Giger O, Maher ER, Gallagher FA. Translating . JCO Precis Oncol. 2018 Mar 29;2:1-12. doi: 10.1200/PO.17.00191. PMID: 30949620; PMCID: PMC6445359.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 33 entries